Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for Goserelin acetate (JAN/USP) Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Email Product
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Goserelin acetate (JAN/USP)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 636,945Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 Bachem AG
    Switzerland
    		 Bachem AG Bubendorf CH R1-CEP 2003-037 - Rev 03 Goserelin 2020-12-18 Valid Chemical 1636
    28/10/2024 BCN Peptides
    Spain
    		 BCN PEPTIDES S.A. St Quinti De Mediona ES R1-CEP 2007-183 - Rev 01 Goserelin 2014-06-12 Valid Chemical 1636